Krystal Biotech (KRYS) Equity Ratio (2021 - 2025)
Historic Equity Ratio for Krystal Biotech (KRYS) over the last 5 years, with Q4 2025 value amounting to 0.91.
- Krystal Biotech's Equity Ratio rose 201.08% to 0.91 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.91, marking a year-over-year increase of 201.08%. This contributed to the annual value of 0.91 for FY2025, which is 201.08% up from last year.
- As of Q4 2025, Krystal Biotech's Equity Ratio stood at 0.91, which was up 201.08% from 0.92 recorded in Q3 2025.
- Krystal Biotech's Equity Ratio's 5-year high stood at 0.97 during Q1 2021, with a 5-year trough of 0.89 in Q1 2022.
- Over the past 5 years, Krystal Biotech's median Equity Ratio value was 0.93 (recorded in 2022), while the average stood at 0.93.
- Examining YoY changes over the last 5 years, Krystal Biotech's Equity Ratio showed a top increase of 367.21% in 2022 and a maximum decrease of 852.18% in 2022.
- Over the past 5 years, Krystal Biotech's Equity Ratio (Quarter) stood at 0.95 in 2021, then fell by 1.33% to 0.94 in 2022, then grew by 1.75% to 0.95 in 2023, then dropped by 5.8% to 0.9 in 2024, then grew by 2.01% to 0.91 in 2025.
- Its Equity Ratio was 0.91 in Q4 2025, compared to 0.92 in Q3 2025 and 0.91 in Q2 2025.